BSEMBioStem Technologies, Inc.
Price Chart
Loading chart...
About BioStem Technologies, Inc. (BSEM)
BioStem Technologies, Inc. (BSEM) is a Biotechnology company headquartered in Pompano Beach, FL, United States whose shares trade over-the-counter on the Pink tier.
BioStem Technologies is a leading innovator focused on harnessing the natural properties of perinatal tissue in the development, manufacture, and commercialization of allografts for regenerative therapies. The Company is focused on manufacturing products that change lives, leveraging its proprietary BioRetain processing method. BioRetain has been developed by applying the latest research in regenerative medicine, focused on maintaining growth factors and preserving tissue structure. BioStem Technologies' quality management system and standard operating procedures have been reviewed and accredited by the American Association of Tissue Banks ("AATB"). These systems and procedures are established per current Good Tissue Practices ("cGTP") and current Good Manufacturing Processes ("cGMP"). Our portfolio of quality brands includes VENDAJE, VENDAJE AC, and VENDAJE OPTIC. Each BioStem Technologies placental allograft is processed at the Company's FDA registered and AATB accredited site in Pompano Beach, Florida.
Products and services
BioStem Technologies produces innovative perinatal tissue-based allografts.
BSEM key facts
- Ticker symbol
- BSEM
- Market tier
- Pink
- Sector
- Healthcare
- Industry
- Biotechnology
- Headquarters
- Pompano Beach, FL, United States
- Country of incorporation
- US
- Year of incorporation
- 2009
- Employees
- 20
- Estimated market cap
- $133.13M (as of Apr 9, 2025)
- Shares outstanding
- 16,703,407
- Reporting standard
- Alternative Reporting Standard
- Audit status
- Unaudited
- Fiscal year end
- 12/31
- Latest filing
- Quarterly Report (Sep 30, 2024)
BioStem Technologies, Inc. leadership
- Jason Matuszewski — CEO, Co-Founder
- Andrew VanVurst — COO, Co-Founder
- Michael Fortunato — CFO
- Shawn McCarrey — Chief Commercial Officer
Explore more: Biotechnology stocks · Healthcare sector · Pink stocks · OTC stocks starting with B
Press Releases
Loading press releases...
Latest News
Loading news...
Key Statistics
Major Holders
Loading...
Loading modules...
AI-Powered Stock Analysis
Get a concise 600-word investment analysis for BioStem Technologies, Inc. (BSEM) prioritizing the most recent news and developments. Our AI focuses on today's breaking news first, then recent company developments, business updates, strategic initiatives, and current market positioning. Get the most relevant and current analysis available.
Still in beta - Please send feedback after generating your analysis to help us improve!
Smart investment analysis prioritizing breaking news, then recent company developments and strategic insights - completely free!
More Biotechnology Companies on OTC Markets
Investor Reviews
Investor Reviews (0)
Loading reviews...
Company Profile
Loading company profile data...
Contact Information
Company Leadership
Company Officers
Social Media
Business Details
Stock Details
Loading modules...